Literature DB >> 9488471

Flexible positioning of the telomerase-associated nuclease leads to preferential elimination of nontelomeric DNA.

E C Greene1, J Bednenko, D E Shippen.   

Abstract

In addition to a reverse transcriptase activity, telomerase is associated with a DNA endonuclease that removes nucleotides from a primer 3' terminus prior to telomere repeat addition. Here we examine the DNA specificity of the primer cleavage-elongation reaction carried out by the Euplotes crassus telomerase. We show that the primer cleavage activity copurified with the E. crassus telomerase polymerase, indicating that it either is an intrinsic property of telomerase or is catalyzed by a tightly associated factor. Using chimeric primers containing stretches of telomeric DNA that could be precisely positioned on the RNA template, we found that the cleavage site is more flexible than originally proposed. Primers harboring mismatches in dT tracts that aligned opposite nucleotides 37 to 40 in the RNA template were cleaved to eliminate the mismatched residues along with the adjacent 3' sequence. The cleaved product was then elongated to generate perfect telomeric repeats. Mismatches in dG tracts were not removed, implying that the nuclease does not track coordinately with the polymerase active site. Our data indicate that the telomerase-associated nuclease could provide a rudimentary proofreading function in telomere synthesis by eliminating mismatches between the DNA primer and the 5' region of the telomerase RNA template.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488471      PMCID: PMC108869          DOI: 10.1128/MCB.18.3.1544

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  Telomerase and retrotransposons: which came first?

Authors:  T H Eickbush
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

3.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

4.  The accuracy of reverse transcriptase from HIV-1.

Authors:  J D Roberts; K Bebenek; T A Kunkel
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

5.  A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.

Authors:  C W Greider; E H Blackburn
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

6.  Variable telomeric repeat synthesis in Paramecium tetraurelia is consistent with misincorporation by telomerase.

Authors:  M McCormick-Graham; W J Haynes; D P Romero
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

7.  Reverse transcriptase motifs in the catalytic subunit of telomerase.

Authors:  J Lingner; T R Hughes; A Shevchenko; M Mann; V Lundblad; T R Cech
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

8.  On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase.

Authors:  N Battula; L A Loeb
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

9.  Control of telomere growth by interactions of RAP1 with the most distal telomeric repeats.

Authors:  A Krauskopf; E H Blackburn
Journal:  Nature       Date:  1996-09-26       Impact factor: 49.962

10.  Large scale synchronous mating and the study of macronuclear development in Euplotes crassus.

Authors:  M Roth; M Lin; D M Prescott
Journal:  J Cell Biol       Date:  1985-07       Impact factor: 10.539

View more
  10 in total

1.  Characterization of the interaction between the nuclease and reverse transcriptase activity of the yeast telomerase complex.

Authors:  H Niu; J Xia; N F Lue
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  A human telomerase-associated nuclease.

Authors:  Rena Oulton; Lea Harrington
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

3.  The MRT-1 nuclease is required for DNA crosslink repair and telomerase activity in vivo in Caenorhabditis elegans.

Authors:  Bettina Meier; Louise J Barber; Yan Liu; Ludmila Shtessel; Simon J Boulton; Anton Gartner; Shawn Ahmed
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

4.  Developmentally programmed assembly of higher order telomerase complexes with distinct biochemical and structural properties.

Authors:  E C Greene; D E Shippen
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

5.  Reiterative dG addition by Euplotes crassus telomerase during extension of non-telomeric DNA.

Authors:  J Bednenko; M Melek; D E Shippen
Journal:  Nucleic Acids Res       Date:  1998-09-01       Impact factor: 16.971

6.  Developmentally regulated telomerase activity is correlated with chromosomal healing during chromatin diminution in Ascaris suum.

Authors:  L Magnenat; H Tobler; F Müller
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

7.  Telomerase in kinetoplastid parasitic protozoa.

Authors:  M I Cano; J M Dungan; N Agabian; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  Expression of mutated Paramecium telomerase RNAs in vivo leads to templating errors that resemble those made by retroviral reverse transcriptase.

Authors:  A J Ye; W J Haynes; D P Romero
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

9.  Human telomerase catalyzes nucleolytic primer cleavage.

Authors:  Sylvain Huard; Chantal Autexier
Journal:  Nucleic Acids Res       Date:  2004-04-19       Impact factor: 16.971

10.  Template requirements for telomerase translocation in Kluyveromyces lactis.

Authors:  Dana H Underwood; Robert P Zinzen; Michael J McEachern
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.